Neurodegenerative Diseases Inserm/UEVE UMR 861, I-Stem, AFM Genopole Campus 1, 5 rue Henri Desbruères, 91030 EVRY Cedex Tel +33 1 6990 8523 aperrier@inserm.fr Laboratory Website Drug discovery for genetic diseases: Screening technologies are applied to identify chemical compounds able to inhibit REST function, a major target gene in Huntington’s disease, and will serve as a paradigm for high-throughput screening approaches applied to neurological disorders.
CEA Saclay - Porte Nord, D36, Saclay, France